These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7756441)

  • 1. A sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseases.
    Osman I; Gaillard O; Meillet D; Bordas-Fonfrède M; Gervais A; Schuller E; Delattre J; Legrand A
    Eur J Clin Chem Clin Biochem; 1995 Jan; 33(1):53-8. PubMed ID: 7756441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-resolved immunofluorometric assay of complement C3: application to cerebrospinal fluid.
    Gaillard O; Meillet D; Diemert MC; Musset L; Delattre J; Schuller E; Galli J
    Clin Chem; 1993 Feb; 39(2):309-12. PubMed ID: 8432021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid.
    Carlsson J; Armstrong VW; Reiber H; Felgenhauer K; Seidel D
    Clin Chim Acta; 1991 Feb; 196(2-3):167-76. PubMed ID: 2029783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal origin of CSF ribonuclease. Differences between infectious processes of the nervous system and multiple sclerosis.
    Allinquant B; Musenger C; Schuller E
    Acta Neurol Scand; 1984 Jul; 70(1):12-9. PubMed ID: 6206680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid levels of biotin in various neurological disorders.
    Anagnostouli M; Livaniou E; Nyalala JO; Evangelatos G; Zournas C; Ithakissios DS; Papageorgiou C
    Acta Neurol Scand; 1999 Jun; 99(6):387-92. PubMed ID: 10577274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal synthesis of IgM in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation.
    Sharief MK; Keir G; Thompson EJ
    J Neurol Sci; 1990 May; 96(2-3):131-42. PubMed ID: 2115907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal IgG synthesis in multiple sclerosis and other neurological diseases: a comparative evaluation by IgG-index and isoelectric focusing.
    Poloni M; Rocchelli B; Scelsi R; Pinelli P
    J Neurol; 1979 Oct; 221(4):245-55. PubMed ID: 92550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid.
    Arneth B; Birklein F
    Acta Neurol Scand; 2009 Jan; 119(1):39-44. PubMed ID: 18573131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
    Rawes JA; Calabrese VP; Khan OA; DeVries GH
    Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders.
    Melegos DN; Freedman MS; Diamandis EP
    Prostaglandins; 1997 Jul; 54(1):463-74. PubMed ID: 9271784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders.
    Kapaki E; Segditsa J; Papageorgiou C
    Acta Neurol Scand; 1989 May; 79(5):373-8. PubMed ID: 2545071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and clinical validation of a time-resolved immunofluorometric assay (TR-IFMA) for canine C-reactive protein in serum.
    Parra MD; Tuomola M; Cabezas-Herrera J; Cerón JJ
    Vet Res Commun; 2006 Feb; 30(2):113-26. PubMed ID: 16400598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine C-reactive protein measurements in cerebrospinal fluid by a time-resolved immunofluorimetric assay.
    Martínez-Subiela S; Caldin M; Parra MD; Ottolini N; Bertolini G; Bernal LJ; García-Martinez JD; Cerón JJ
    J Vet Diagn Invest; 2011 Jan; 23(1):63-7. PubMed ID: 21217029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of cerebrospinal fluid IgG in the diagnosis of multiple sclerosis.
    Willoughby EW
    Proc Aust Assoc Neurol; 1976; 13():127-33. PubMed ID: 829365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation.
    Gaillard O; Gervais A; Meillet D; Plassart E; Fontaine B; Lyon-Caen O; Delattre J; Schuller E
    J Neurol Sci; 1998 Jun; 158(2):180-6. PubMed ID: 9702689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
    Kastenbauer S; Koedel U; Wick M; Kieseier BC; Hartung HP; Pfister HW
    J Neuroimmunol; 2003 Apr; 137(1-2):210-7. PubMed ID: 12667665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.
    Trentini A; Castellazzi M; Romani A; Squerzanti M; Baldi E; Caniatti ML; Pugliatti M; Granieri E; Fainardi E; Bellini T; Cervellati C
    J Neurol Sci; 2017 Jun; 377():133-136. PubMed ID: 28477683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.